Search | IOVS | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina November 2024

Patient-Reported Outcomes in RLBP1 Retinal Dystrophy: Longitudinal Assessment in a Prospective Natural History Study

PDF

James Whelan; Jane Green; Marie Burstedt; Erin Greco; Xiao Ni; Claudio Spera; Anmol Mullins; Jean-Yves Deslandes; Zhenzhong Su; Michael Wald; Cynthia L. Grosskreutz; Guillaume Normand; Arnaud Charil; Darlene Lu; Kalliopi Stasi; Karen Holopigian
TAGS: natural history, patient self-report, pik3ca-related overgrowth spectrum, questionnaires, rasch model, retinal dystrophies, vision, significance
Trans. Vis. Sci. Tech.. 2024; 13(11):16. https://doi.org/10.1167/tvst.13.11.16

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Biomarker identification by proteomic analysis of vitreous humor and plasma from diabetic retinopathy patients

Qin Zhang; Angela Banks; Rebecca Stacy; Ning Li; Yesel Kim; Lori Jennings; Nancy Finkel; Joseph Loureiro; Anfan Wu; Amy Chen; Cynthia L Grosskreutz; Qian Huang; Ganesh Prasanna

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):555.

ARVO Annual Meeting Abstract July 2018

Topical VEGF receptor inhibitor, LHA510, did not demonstrate efficacy in a Proof-of-Concept study in patients with neovascular age-related macular degeneration (nv AMD)

Stephen H Poor; Christopher M Adams; Michael Ferriere; Andreas Weichselberger; Cynthia L Grosskreutz; Georges Weissgerber

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2394.

ARVO Annual Meeting Abstract June 2017

Central visual function over two-year follow-up of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Kalliopi Stasi; Michael Wald; Marie Burstedt; Jane Green; James Whelan; Michael Rosol; Xiao Ni; Zhenzhong Su; Jean-Yves Deslandes; Cynthia L Grosskreutz; Karen Holopigian

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3244.

ARVO Annual Meeting Abstract June 2017

Humphrey visual field and flicker electroretinogram changes over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Karen Holopigian; Jane Green; James Whelan; Marie Burstedt; Zhenzhong Su; Jean-Yves Deslandes; Xiao Ni; Michael Wald; Cynthia L Grosskreutz; Kalliopi Stasi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3246.

ARVO Annual Meeting Abstract June 2017

Full-field stimulus threshold dark-adaptation kinetics over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Xiao Ni; Michael Wald; Marie Burstedt; Jane Green; James Whelan; Zhenzhong Su; Jean-Yves Deslandes; Cynthia L Grosskreutz; Kalliopi Stasi; Karen Holopigian

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3249.

ARVO Annual Meeting Abstract June 2017

Cross-sectional evaluation of patient-reported outcomes (PROs) in patients with RLBP1 retinitis pigmentosa enrolled in a Natural History Study

Anmol Mullins; Marie Burstedt; Jane Green; James Whelan; Brigitte Sloesen; Xiao Ni; Zhenzhong Su; Michael Wald; Cynthia L Grosskreutz; Kalliopi Stasi; Karen Holopigian; Jean-Yves Deslandes

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3251.

ARVO Annual Meeting Abstract June 2017

Baseline characteristics of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Jane Green; Marie Burstedt; James H Whelan; Yunsheng He; Zhenzhong Su; Xiao Ni; Michael Wald; Guillaume Normand; Jean-Yves Deslandes; Cynthia L Grosskreutz; Karen Holopigian; Kalliopi Stasi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3254.

ARVO Annual Meeting Abstract June 2017

Longitudinal evaluation of optical coherence tomography and color fundus photography over 2 year follow up in patients with RLBP1 retinitis pigmentosa

James H Whelan; Guillaume Normand; Michael Maker; Marie Burstedt; Jane Green; Michael Wald; Zhenzhong Su; Xiao Ni; Karen Holopigian; Cynthia L Grosskreutz; Kalliopi Stasi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3255.

ARVO Annual Meeting Abstract September 2016

A first in human study of Intravitreal (IVT) CLG561 in Subjects with Advanced Age-Related Macular Degeneration (AMD)

Louis C Glazer; Jonathan G. Williams; Carmelina M Gordon; Pravin U Dugel; Mark Milton; Thomas Valencia; Ulf Klein; Sandrine Kretz; Kinfemichael Gedif; Cynthia L Grosskreutz; Parisa Zamiri

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2672.

ARVO Annual Meeting Abstract September 2016

A Proof of Concept Study of Intravitreal (IVT) LFG316 In Patients with Neovascular Age Realted Macular Degeneration (nAMD)

Ron P Gallemore; Michael J Elman; Mark Milton; Parisa Zamiri; Cynthia L Grosskreutz

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4986.

ARVO Annual Meeting Abstract June 2015

Performance of automated hyperemia assessment in allergic conjunctivitis interventional study

Michael J Wald; Bruno Lay; Ronan Danno; Cynthia L Grosskreutz; Sudeep Chandra

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4041.

ARVO Annual Meeting Abstract June 2015

A novel imaging technique to non-invasively track molecules in the eye

Guillaume Normand; Jan Penraat; Joy Ghosh; Kellyann Kovach; Mikele Simkins; Michael Rosol; Cynthia L Grosskreutz; Sudeep Chandra

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4115.

Genetics February 2014

Disruption of the Blood–Aqueous Barrier and Lens Abnormalities in Mice Lacking Lysyl Oxidase-Like 1 (LOXL1)

PDF

Janey L. Wiggs; Basil Pawlyk; Edward Connolly; Michael Adamian; Joan W. Miller; Louis R. Pasquale; Ramez I. Haddadin; Cynthia L. Grosskreutz; Douglas J. Rhee; Tiansen Li
TAGS: blood-aqueous barrier, lens (device), lens, crystalline, mice, mice, knockout, oxidase, phenotype, elastin, proteins, fluorescein angiography
Invest. Ophthalmol. Vis. Sci.. 2014; 55(2):856-864. https://doi.org/10.1167/iovs.13-13033

Glaucoma August 2010

Global Gene Expression Changes in Rat Retinal Ganglion Cells in Experimental Glaucoma

PDF

Dan Yi Wang; Arjun Ray; Kathryn Rodgers; Ceren Ergorul; Bradley T. Hyman; Wei Huang; Cynthia L. Grosskreutz
TAGS: gene expression, genes, glaucoma, retinal ganglion cells, intraocular pressure, stat3 protein, raised intraocular pressure
Invest. Ophthalmol. Vis. Sci.. 2010; 51(8):4084-4095. https://doi.org/10.1167/iovs.09-4864

Includes: Supplemental Content

Glaucoma June 2010

Calpain Activation in Experimental Glaucoma

PDF

Wei Huang; John Fileta; Ian Rawe; Juan Qu; Cynthia L. Grosskreutz
TAGS: calpain, cytokinesis, glaucoma, raised intraocular pressure, calcineurin, intraocular pressure, spectrin
Invest. Ophthalmol. Vis. Sci.. 2010; 51(6):3049-3054. https://doi.org/10.1167/iovs.09-4364

ARVO Annual Meeting Abstract April 2010

Transcriptional Up-Regulation of Stat3 and Stat5a in Experimental Glaucoma

D. Wang; K. Rodgers; Y. Ben; A. Ray; C. L. Grosskreutz

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2116.

ARVO Annual Meeting Abstract April 2010

Autophagy in Experimental Glaucoma

K. Rodgers; D. Wang; Y. Ben; J. Qu; C. L. Grosskreutz

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2117.

ARVO Annual Meeting Abstract April 2010

Predictors of Success of Selective Laser Trabeculoplasty

S. Jea; L. R. Pasquale; C. L. Grosskreutz; D. J. Rhee

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4420.

ARVO Annual Meeting Abstract April 2010

Calpain is Activated in Retinal Ganglion Cells in Experimental Glaucoma

J. Qu; W. Huang; C. L. Grosskreutz

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6097.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Patient-Reported Outcomes in RLBP1 Retinal Dystrophy: Longitudinal Assessment in a Prospective Natural History Study

Biomarker identification by proteomic analysis of vitreous humor and plasma from diabetic retinopathy patients

Topical VEGF receptor inhibitor, LHA510, did not demonstrate efficacy in a Proof-of-Concept study in patients with neovascular age-related macular degeneration (nv AMD)

Central visual function over two-year follow-up of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Humphrey visual field and flicker electroretinogram changes over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Full-field stimulus threshold dark-adaptation kinetics over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Cross-sectional evaluation of patient-reported outcomes (PROs) in patients with RLBP1 retinitis pigmentosa enrolled in a Natural History Study

Baseline characteristics of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Longitudinal evaluation of optical coherence tomography and color fundus photography over 2 year follow up in patients with RLBP1 retinitis pigmentosa

A first in human study of Intravitreal (IVT) CLG561 in Subjects with Advanced Age-Related Macular Degeneration (AMD)

A Proof of Concept Study of Intravitreal (IVT) LFG316 In Patients with Neovascular Age Realted Macular Degeneration (nAMD)

Performance of automated hyperemia assessment in allergic conjunctivitis interventional study

A novel imaging technique to non-invasively track molecules in the eye

Disruption of the Blood–Aqueous Barrier and Lens Abnormalities in Mice Lacking Lysyl Oxidase-Like 1 (LOXL1)

Global Gene Expression Changes in Rat Retinal Ganglion Cells in Experimental Glaucoma

Calpain Activation in Experimental Glaucoma

Transcriptional Up-Regulation of Stat3 and Stat5a in Experimental Glaucoma

Autophagy in Experimental Glaucoma

Predictors of Success of Selective Laser Trabeculoplasty

Calpain is Activated in Retinal Ganglion Cells in Experimental Glaucoma

To View More...

You must be signed into an individual account to use this feature.